Rapastinel Fails to Outperform Placebo in Phase 3 Studies | Psychiatry & Behavioral Health Learning Network - Psych Congress Network

Submitted by Anonymous (not verified) on Tue, 03/12/2019 - 18:24

Rapastinel Fails to Outperform Placebo in Phase 3 Studies | Psychiatry & Behavioral Health Learning Network  Psych Congress NetworkThe investigational antidepressant rapastinel failed to outperform placebo in three phase 3 trials studying its use as an adjunctive treatment for major depressive ...